History of Research on Antisense Oligonucleotide Analogs

In the search for novel therapeutics, antisense oligonucleotide (ASO) analogs have been a major focus of research for over 40 years.  They use the antisense strategy, namely they have a nucleic acid base sequence that is complementary to a portion of a specific mRNA that is produced in the cell, or...

Full description

Saved in:
Bibliographic Details
Published inSubstantia (Firenze) Vol. 5; no. 1
Main Author Cohen, Jack S.
Format Journal Article
LanguageEnglish
Published Firenze University Press 01.03.2021
Subjects
Analogs
Antisense
Oligonucleotide
RNA
Therapeutic
Online AccessGet full text
ISSN2532-3997
2532-3997
DOI10.36253/Substantia-964

Cover

Abstract In the search for novel therapeutics, antisense oligonucleotide (ASO) analogs have been a major focus of research for over 40 years.  They use the antisense strategy, namely they have a nucleic acid base sequence that is complementary to a portion of a specific mRNA that is produced in the cell, or to a viral RNA, in order to selectively inhibit gene expression. Oligonucleotides need to be chemically modified to stabilize them against hydrolysis by endogenous nucleases. Until now several phosphorothioate (PS) oligonucleotide analogs have been approved by the FDA for human use. This article seeks to provide a history of this subject to date.
AbstractList In the search for novel therapeutics, antisense oligonucleotide (ASO) analogs have been a major focus of research for over 40 years.  They use the antisense strategy, namely they have a nucleic acid base sequence that is complementary to a portion of a specific mRNA that is produced in the cell, or to a viral RNA, in order to selectively inhibit gene expression. Oligonucleotides need to be chemically modified to stabilize them against hydrolysis by endogenous nucleases. Until now several phosphorothioate (PS) oligonucleotide analogs have been approved by the FDA for human use. This article seeks to provide a history of this subject to date.
Author Cohen, Jack S.
Author_xml – sequence: 1
  givenname: Jack S.
  surname: Cohen
  fullname: Cohen, Jack S.
BookMark eNp1kE9LAzEQxYNUsNaeve4XWDub3c0mx1LUFgoF_5zDbDZZU9aNJOmh397QiorgaYY3vN_MvGsyGd2oCbkt4K5ktC4Xz4c2RByjxVyw6oJMk0jzUohm8qu_IvMQ9gBAecME8Cnhaxui88fMmexJB41evWVuzJYJFfQYdLYbbO_Ggxq0i7bTaYKD68MNuTQ4BD3_qjPy-nD_slrn293jZrXc5oqyssqxVgyBV1oI2lSMc1MgpRp4CQJKzqBqeZE-aIrOdLVpFAdFC60YRY5tjeWMbM7czuFefnj7jv4oHVp5EpzvJfpo03myadEIalQnACswFRc0raih6BQVQrDEWpxZyrsQvDbfvALkKUf5k6NMOSZH_cehbMRo3Rg92uFf3ydfSnuK
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2024_139186
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.36253/Substantia-964
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals*
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2532-3997
ExternalDocumentID oai_doaj_org_article_7baf92fcd90a40f4892038501dc29996
10_36253_Substantia_964
GroupedDBID 3J0
AAFWJ
AAYXX
AFPKN
AGVNC
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
M~E
OK1
ID FETCH-LOGICAL-c2634-a5c6a084e99274688f1a22e08309038604b8162571dfd5f7c80c21ec62a8ab5a3
IEDL.DBID DOA
ISSN 2532-3997
IngestDate Wed Aug 27 01:32:12 EDT 2025
Thu Apr 24 22:53:45 EDT 2025
Tue Jul 01 01:48:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2634-a5c6a084e99274688f1a22e08309038604b8162571dfd5f7c80c21ec62a8ab5a3
OpenAccessLink https://doaj.org/article/7baf92fcd90a40f4892038501dc29996
ParticipantIDs doaj_primary_oai_doaj_org_article_7baf92fcd90a40f4892038501dc29996
crossref_primary_10_36253_Substantia_964
crossref_citationtrail_10_36253_Substantia_964
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-03-01
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-01
  day: 01
PublicationDecade 2020
PublicationTitle Substantia (Firenze)
PublicationYear 2021
Publisher Firenze University Press
Publisher_xml – name: Firenze University Press
SSID ssj0002876908
Score 2.1666844
Snippet In the search for novel therapeutics, antisense oligonucleotide (ASO) analogs have been a major focus of research for over 40 years.  They use the antisense...
SourceID doaj
crossref
SourceType Open Website
Enrichment Source
Index Database
SubjectTerms Analogs
Antisense
Oligonucleotide
RNA
Therapeutic
Title History of Research on Antisense Oligonucleotide Analogs
URI https://doaj.org/article/7baf92fcd90a40f4892038501dc29996
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwELVQF1gQn6J8yQMDi6ntOo49loqqYoCFSt2i81dVVCWIloF_j52kpQyIhTVyovhd7HvnnN5D6EYzq3xMtCQIJojIvCMKmCSQa89yHwk61GqfT3I8EY_TbLpl9ZV6whp54Aa4Xm4gaB6s0xQEDUJpnn5mUeYsT2Q97b5U061i6rU-Mspj2acaLZ-4R2f9XlqIyZh3DkRL8SMNban112lldID2Wz6IB817HKIdXx6h3eHahu0YqUbI4xNXAa_b5HBV4kGZbJTLpcfPi_msKpMucbWaO4-Tzkg1W56gyejhZTgmrd0BsVz2BYHMSqBKeK1jqSiVCgw495EjpbMUJakwisWp5MwFl4XcKmo581ZyUGAy6J-iTlmV_gxhB16lpQlZYMKAMeB130DuIHAGznTR3Xr2hW21wJMlxaKINUENV_ENVxHh6qLbzQ1vjQzG70PvE5ybYUm_ur4Qo1q0US3-iur5fzzkAu3x1IFSd4xdos7q_cNfRQqxMtf11_IFA5nFvw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=History+of+Research+on+Antisense+Oligonucleotide+Analogs&rft.jtitle=Substantia+%28Firenze%29&rft.au=Jack+S.+Cohen&rft.date=2021-03-01&rft.pub=Firenze+University+Press&rft.eissn=2532-3997&rft.volume=5&rft.issue=1&rft_id=info:doi/10.36253%2FSubstantia-964&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7baf92fcd90a40f4892038501dc29996
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2532-3997&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2532-3997&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2532-3997&client=summon